Arteriosclerosis
Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
Subtype terms (6)
More specific conditions that are subtypes of Arteriosclerosis in the MeSH hierarchy.
- Arteriolosclerosis
- Arteriosclerosis Obliterans
5 drugs (4 approved, 1 experimental)
- Atherosclerosis
291 drugs (167 approved, 124 experimental)
- Coronary Artery Disease
448 drugs (273 approved, 175 experimental)
- Intracranial Arteriosclerosis
30 drugs (24 approved, 6 experimental)
- Penetrating Atherosclerotic Ulcer
Drugs by status
Approved for this indication (3)
Phase 4 trials (17)
Phase 3 trials (2)
Phase 2 trials (4)
Phase 1 trials (2)
Other trials (4)
Organizations
Organization Involved with Phase 4 Indications (59)
- Astellas
- Gilead Sciences
- Schering-Plough
- Merck
- Novo Nordisk
- Pfizer
- Nabi Biopharmaceuticals
- Boehringer Ingelheim
- Otsuka
- CardioVascular Research Foundation, Korea
- University of Roma La Sapienza
- Husson University
- Associations for Establishment of Evidence in Interventions
- Harvard University
- Dianet Dialysis Centers
- University of Washington
- Harbin Medical University
- Italian Society of Invasive Cardiology
- Kronos Longevity Research Institute
- Kumamoto University
- Kaiser Franz Josef Hospital
- Monash University
- Nara Medical University
- Queen's University, Belfast
- Seoul National University
- Tufts University
- University Hospital Koge
- University of Southern California
- Utrecht University
- Yale University
- +29 more
Organization Involved with Phase 3 Indications (12)
Organization Involved with Phase 2 Indications (23)
- Avant Immunotherapeutics
- Venturis Therapeutics
- Guangzhou Yipinhong Pharmaceutical CO.,LTD
- Swiss National Science Foundation
- Swiss Federal Institute of Technology
- Hebei University
- D'Annunzio University of Chieti–Pescara
- Hoosier Cancer Research Network
- Jilin University
- Nanjing Medical University
- Qingdao University
- RTI International
- Sichuan University
- University of Milan
- Jiao Tong University
- Wilhelminenspital der Stadt Wien
- Tianjin Medical University
- University of Massachusetts
- Catholic University of Sacred Heart, Rome
- Inova Health System
- Mercy Gilbert Medical Center
- Shijiazhuang Pharma Group (CSPC)
- Heilongjiang University of Traditional Chinese Medicine
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (9)